177 related articles for article (PubMed ID: 25775165)
1. Depressive symptoms, antidepressant medication use, and new onset of diabetes in participants of the diabetes prevention program and the diabetes prevention program outcomes study.
Marrero DG; Ma Y; de Groot M; Horton ES; Price DW; Barrett-Connor E; Carnethon MR; Knowler WC;
Psychosom Med; 2015 Apr; 77(3):303-10. PubMed ID: 25775165
[TBL] [Abstract][Full Text] [Related]
2. Depressive Symptoms, Antidepressant Medication Use, and Inflammatory Markers in the Diabetes Prevention Program.
de Groot M; Marrero D; Mele L; Doyle T; Schwartz F; Mather KJ; Goldberg R; Price DW; Ma Y; Knowler WC;
Psychosom Med; 2018; 80(2):167-173. PubMed ID: 29016549
[TBL] [Abstract][Full Text] [Related]
3. Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study.
Aroda VR; Knowler WC; Crandall JP; Perreault L; Edelstein SL; Jeffries SL; Molitch ME; Pi-Sunyer X; Darwin C; Heckman-Stoddard BM; Temprosa M; Kahn SE; Nathan DM;
Diabetologia; 2017 Sep; 60(9):1601-1611. PubMed ID: 28770322
[TBL] [Abstract][Full Text] [Related]
4. Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program.
Rubin RR; Ma Y; Marrero DG; Peyrot M; Barrett-Connor EL; Kahn SE; Haffner SM; Price DW; Knowler WC;
Diabetes Care; 2008 Mar; 31(3):420-6. PubMed ID: 18071002
[TBL] [Abstract][Full Text] [Related]
5. Long-term Association of Depression Symptoms and Antidepressant Medication Use With Incident Cardiovascular Events in the Look AHEAD (Action for Health in Diabetes) Clinical Trial of Weight Loss in Type 2 Diabetes.
Hazuda HP; Gaussoin SA; Wing RR; Yanovski SZ; Johnson KC; Coday M; Wadden TA; Horton ES; Van Dorsten B; Knowler WC;
Diabetes Care; 2019 May; 42(5):910-918. PubMed ID: 30833373
[TBL] [Abstract][Full Text] [Related]
6. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study.
Perreault L; Pan Q; Mather KJ; Watson KE; Hamman RF; Kahn SE;
Lancet; 2012 Jun; 379(9833):2243-51. PubMed ID: 22683134
[TBL] [Abstract][Full Text] [Related]
7. Depression symptoms and antidepressant medicine use in Diabetes Prevention Program participants.
Rubin RR; Knowler WC; Ma Y; Marrero DG; Edelstein SL; Walker EA; Garfield SA; Fisher EB;
Diabetes Care; 2005 Apr; 28(4):830-7. PubMed ID: 15793181
[TBL] [Abstract][Full Text] [Related]
8. Four-year analysis of cardiovascular disease risk factors, depression symptoms, and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes.
Rubin RR; Peyrot M; Gaussoin SA; Espeland MA; Williamson D; Faulconbridge LF; Wadden TA; Ewing L; Safford M; Evans-Hudnall G; Wing RR; Knowler WC;
Diabetes Care; 2013 May; 36(5):1088-94. PubMed ID: 23359362
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular disease risk factors, depression symptoms and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes.
Rubin RR; Gaussoin SA; Peyrot M; DiLillo V; Miller K; Wadden TA; West DS; Wing RR; Knowler WC;
Diabetologia; 2010 Aug; 53(8):1581-9. PubMed ID: 20422396
[TBL] [Abstract][Full Text] [Related]
10. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS.
Diabetes Prevention Program Research Group
Diabetes Care; 2012 Apr; 35(4):723-30. PubMed ID: 22442395
[TBL] [Abstract][Full Text] [Related]
11. Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention Program.
Walker EA; Molitch M; Kramer MK; Kahn S; Ma Y; Edelstein S; Smith K; Johnson MK; Kitabchi A; Crandall J
Diabetes Care; 2006 Sep; 29(9):1997-2002. PubMed ID: 16936143
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Shared Decision-making for Diabetes Prevention: 12-Month Results from the Prediabetes Informed Decision and Education (PRIDE) Trial.
Moin T; Duru OK; Turk N; Chon JS; Frosch DL; Martin JM; Jeffers KS; Castellon-Lopez Y; Tseng CH; Norris K; Mangione CM
J Gen Intern Med; 2019 Nov; 34(11):2652-2659. PubMed ID: 31471729
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and correlates of depressive disorders in elderly with type 2 diabetes in primary health care settings.
Shehatah A; Rabie MA; Al-Shahry A
J Affect Disord; 2010 Jun; 123(1-3):197-201. PubMed ID: 19804911
[TBL] [Abstract][Full Text] [Related]
14. Exploring residual risk for diabetes and microvascular disease in the Diabetes Prevention Program Outcomes Study (DPPOS).
Perreault L; Pan Q; Aroda VR; Barrett-Connor E; Dabelea D; Dagogo-Jack S; Hamman RF; Kahn SE; Mather KJ; Knowler WC;
Diabet Med; 2017 Dec; 34(12):1747-1755. PubMed ID: 28833481
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Weight Loss With Metformin or Lifestyle Intervention in the Diabetes Prevention Program Outcomes Study.
Apolzan JW; Venditti EM; Edelstein SL; Knowler WC; Dabelea D; Boyko EJ; Pi-Sunyer X; Kalyani RR; Franks PW; Srikanthan P; Gadde KM;
Ann Intern Med; 2019 May; 170(10):682-690. PubMed ID: 31009939
[TBL] [Abstract][Full Text] [Related]
16. Metformin Should Not Be Used to Treat Prediabetes.
Davidson MB
Diabetes Care; 2020 Sep; 43(9):1983-1987. PubMed ID: 32936780
[TBL] [Abstract][Full Text] [Related]
17. The comparative efficacy of lifestyle intervention and metformin by educational attainment in the Diabetes Prevention Program.
O'Brien MJ; Whitaker RC; Yu D; Ackermann RT
Prev Med; 2015 Aug; 77():125-30. PubMed ID: 26024851
[TBL] [Abstract][Full Text] [Related]
18. The influence of patients' attributions of the immediate effects of treatment of depression on long-term effectiveness of behavioural activation and antidepressant medication.
Moradveisi L; Huibers MJ; Arntz A
Behav Res Ther; 2015 Jun; 69():83-92. PubMed ID: 25898343
[TBL] [Abstract][Full Text] [Related]
19. Impact of intensive lifestyle intervention on depression and health-related quality of life in type 2 diabetes: the Look AHEAD Trial.
Rubin RR; Wadden TA; Bahnson JL; Blackburn GL; Brancati FL; Bray GA; Coday M; Crow SJ; Curtis JM; Dutton G; Egan C; Evans M; Ewing L; Faulconbridge L; Foreyt J; Gaussoin SA; Gregg EW; Hazuda HP; Hill JO; Horton ES; Hubbard VS; Jakicic JM; Jeffery RW; Johnson KC; Kahn SE; Knowler WC; Lang W; Lewis CE; Montez MG; Murillo A; Nathan DM; Patricio J; Peters A; Pi-Sunyer X; Pownall H; Rejeski WJ; Rosenthal RH; Ruelas V; Toledo K; Van Dorsten B; Vitolins M; Williamson D; Wing RR; Yanovski SZ; Zhang P;
Diabetes Care; 2014 Jun; 37(6):1544-53. PubMed ID: 24855155
[TBL] [Abstract][Full Text] [Related]
20. Metformin in Prevention of Type 2 Diabetes.
Snehalatha C; Priscilla S; Nanditha A; Arun R; Satheesh K; Ramachandran A
J Assoc Physicians India; 2018 Mar; 66(3):60-3. PubMed ID: 30341871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
